Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer.
Sjoquist KM, Martin A, Pavlakis N, Goldstein D, Tsobanis E, Moses D, Maher R, Hague W, Gebski V, Stockler MR, Simes RJ; Australasian Gastro-Intestinal Trials Group (AGITG). Sjoquist KM, et al. Among authors: gebski v. J Cancer Res Clin Oncol. 2023 Jul;149(8):4959-4965. doi: 10.1007/s00432-022-04404-4. Epub 2022 Oct 31. J Cancer Res Clin Oncol. 2023. PMID: 36310299 Free PMC article. Clinical Trial.
Dynamic balanced randomization for clinical trials.
Signorini DF, Leung O, Simes RJ, Beller E, Gebski VJ, Callaghan T. Signorini DF, et al. Among authors: gebski vj. Stat Med. 1993 Dec 30;12(24):2343-50. doi: 10.1002/sim.4780122410. Stat Med. 1993. PMID: 8134737
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
Byrne MJ, Gebski V, Forbes J, Tattersall MH, Simes RJ, Coates AS, Dewar J, Lunn M, Flower C, Gill PG, Stewart J. Byrne MJ, et al. Among authors: gebski v. J Clin Oncol. 1997 Sep;15(9):3141-8. doi: 10.1200/JCO.1997.15.9.3141. J Clin Oncol. 1997. PMID: 9294477 Clinical Trial.
Recruitment to randomised studies.
Hague WE, Gebski VJ, Keech AC. Hague WE, et al. Med J Aust. 2003 Jun 2;178(11):579-81. doi: 10.5694/j.1326-5377.2003.tb05364.x. Med J Aust. 2003. PMID: 12765509 Free PMC article. No abstract available.
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.
Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, North J, Walpole ET, Denham JW; Trans-Tasman Radiation Oncology Group; Australasian Gastro-Intestinal Trials Group. Burmeister BH, et al. Among authors: gebski v. Lancet Oncol. 2005 Sep;6(9):659-68. doi: 10.1016/S1470-2045(05)70288-6. Lancet Oncol. 2005. PMID: 16129366 Clinical Trial.
Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide.
Cebon J, Findlay M, Hargreaves C, Stockler M, Thompson P, Boyer M, Roberts S, Poon A, Scott AM, Kalff V, Garas G, Dowling A, Crawford D, Ring J, Basser R, Strickland A, Macdonald G, Green M, Nowak A, Dickman B, Dhillon H, Gebski V; Australasian Gastro-Intestinal Trials Group (AGITG) Ag0001H Investigators. Cebon J, et al. Among authors: gebski v. Br J Cancer. 2006 Oct 9;95(7):853-61. doi: 10.1038/sj.bjc.6603325. Epub 2006 Sep 5. Br J Cancer. 2006. PMID: 16953241 Free PMC article. Clinical Trial.
427 results